Latest Posts

In September, PathGroup recognizes Prostate Cancer Awareness Month and Ovarian Cancer Awareness Month. Both of these cancers affect a significant population in the United States.

Prostate cancer affects 1 in 9 men in the United States and 1 in 41 men will die from the disease making prostate cancer the second leading cause of cancer death in the U.S.

Ovarian cancer affects 1 in 78 women in the United States and nearly 80% of them will be diagnosed in advanced stages. For this reason, ovarian cancer leads to more deaths than any other cancer of the female reproductive system.

PathGroup offers laboratory testing to help healthcare providers diagnose these types of cancers in their patients. To learn more about those testing options, visit the PathGroup Directory of Services.

NASHVILLE, Sept. 10, 2019 — PathGroup, one of the largest private providers of pathology, clinical and molecular laboratory services in the United States, announced today that Southeastern Pathology Associates has joined the PathGroup family of pathology practices and laboratories.

Click here to read the press release.

Due to the threat of Hurricane Dorian, PathGroup specimen transportation services for the coastal regions of GA, SC and NC will be impacted.

Click here to learn more.

More than 50 million Americans suffer from allergies every year making allergies the sixth leading cause of chronic illness in the United States. Allergies are a common, yet overlooked, disease and the most common health issue that affects children in the U.S. An estimated 4.2 million children in the U.S. have a food allergy to things like peanuts, eggs, milk, wheat, tree nuts, fish and shellfish.

Click here to learn more.

July 28 is World Hepatitis Day. In 2016, every country in the world signed up to eliminate viral hepatitis by 2030 and World Hepatitis Day is an annual reminder to continue that fight. Viral hepatitis (most notably hepatitis A, B, and C) kills an estimated 1.4 million people every year around the world, but these deaths are preventable with early detection.

In the United States, viral hepatitis affects millions of people, with hepatitis C affecting the largest population – about 40,000 new cases of acute hepatitis C every year. An estimated 2.4 million people in the United States are living with chronic hepatitis C, which occurs if acute hepatitis C infection is left untreated.

PathGroup offers many testing options to help healthcare providers diagnose viral hepatitis in their patients. Visit http://www.pathgroup.com/clinical/testing-menu/ for a full list of testing options.

Reported cases of vector-borne diseases – diseases contracted from mosquito or tick bites – have tripled since the early 2000s.

Depending on the patient’s geographic location or recent travel destinations, they could be at risk of contracting diseases from ticks and mosquitos.

To learn more, click here.

May 25 is World Thyroid Day. Thyroid disorders affect an estimated 20 million people in the United States – that’s more than 12% of the U.S. population. Thyroid disorders like hyperthyroidism, hypothyroidism, Graves disease, and even thyroid cancer are caused by abnormal activity in the thyroid that can be detected using laboratory testing. PathGroup offers tests that assist healthcare providers in diagnosing thyroid disorders in their patients. To learn more about these testing options, visit the online Directory of Services.

NASHVILLE, May 1, 2019 — PathGroup, one of the largest private providers of pathology, clinical and molecular laboratory services in the United States, today announced that it has acquired Pathologists Bio-Medical Laboratories (PBM), a leading provider of pathology services based in Dallas.

Click here to read the press release.

Sexually transmitted infections (STIs) are viruses or bacteria spread through sexual contact with an infected individual. Some of the most common STIs are: chlamydia, gonorrhea, trichomonas vaginalis, and mycoplasma genitalium (M. gen). An estimated 20 million new STIs occur every year in the United States.

To learn more, click here.

Colorectal cancer is the third most common cancer in the United States. There are an estimated 140,000 new cases diagnosed every year and about 50,000 people lose their lives to colorectal cancer each year. According to the American Cancer Society, the risk of developing colorectal cancer is slightly lower in women (4.15%) than in men (4.49%).

Click here for more information about Colorectal Cancer Awareness Month.